Home Compare JAZZ vs TCAP.L
Stock Comparison · Structural lead, mixed market

Jazz Pharmaceuticals vs TP ICAP Group: Which Stock Looks Stronger in 2026?

Jazz Pharmaceuticals holds the cleaner structural position, with growth as the main driver and profitability adding further support. TP ICAP still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across growth and profitability, rather than sitting in one isolated gap. Jazz Pharmaceuticals plc leads by 11 points on the overall comparison score.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #4
within Jazz Pharmaceuticals plc's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The clearest structural overlap shows up in investment intensity and margin consistency.

Similarity drivers
investment intensitymargin consistency
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
JAZZ
Jazz Pharmaceuticals plc
56
Peer-Score
Signal qualityHigh
vs
TCAP.L
TP ICAP Group PLC
45
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: JAZZ vs TCAP.L Profitability 35 11 Stability 44 56 Valuation 88 88 Growth 48 22 JAZZ TCAP.L
Gap Ranking
#1 Growth +26
#2 Profitability +24
#3 Stability +12
#4 Valuation
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for JAZZ and TCAP.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer JAZZTCAP.L Relative valuation Structural strength

Jazz Pharmaceuticals plc looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses Forward P/E and peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Jazz Pharmaceuticals plc sits higher in the group on growth, adding to the overall structural advantage.
Profitability
Neither side looks especially strong on profitability, though Jazz Pharmaceuticals plc still ranks somewhat higher.
Growth — Dominant Gap
JAZZ
48
TCAP.L
22
Gap+26in favour of JAZZ

The clearest distance comes from a stronger growth profile.

What keeps the gap from being one-sided

Stability still leans toward TP ICAP Group PLC, so the lead is real without reading as one-way.

What this means for the comparison

Growth is the clearest driver of the lead, with profitability adding further support — though stability still provides a real counterweight.

Explore full peer positioning in AssetNext

Break down the JAZZ vs TCAP.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-profitability comparisons

Explore how JAZZ and TCAP.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.